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The dual effects of the flavonoid quercetin on rat basophilic leukemia cells (RBL-2H3), tumor analog 
mast cells, was studied. Quercetin is known as an anti-inflammatory drug that inhibits mast cell secretion of 
histamine. This study aims to investigate the consequences of varying incubation times with quercetin on 2H3 
cells to histamine release inhibitory action and the effects of long time incubation to the morphology of the 
cells. 
The effect of quercetin on histamine synthesis was also observed. The histamine release from the cells 
was inhibited by quercetin as expected, but the ability of secretion was rapidly recovered when quercetin was 
removed before challenging. Incubation up to 6 hours decreased the inhibitory action, but longer than 6 hours 
increased the inhibitory activity. 
In long time incubation, the cells exhibited cell damage, decreased cell growth, morphological changes, 
and detachment from the underlying surface in proportion with the concentration of quercetin. The instant and 
reversible inhibitory effects of quercetin appear to represent a first phase of actions, while reduced cell growth, 
elevated cell damage and morphological changes seem to be connected to a second phase. 
Consequently, quercetin could be considered as a compound that acts dually on RBL-2H3 cells. 




 Telah diteliti efek ganda flavonoid quercetin terhadap kultur sel Rat Basophilic Leukemia (RBL-2H3), 
suatu sel yang menyerupai sel mast. Quercetin merupakan senyawa anti inflamasi yang dapat menghambat 
pelepasan histamin dari sel mast. Penelitian ini bertujuan mempelajari efek variasi waktu inkubasi sel dengan 
quercetin terhadap aktivitas pelepasan histamin dan mengetahui efek inkubasi terhadap morfologi sel. 
Dari penelitian diperoleh hasil bahwa pelepasan histamin dihambat oleh quercetin, tetapi kemampuan 
pelepasan histamin segera diperoleh kembali secara cepat jika quercetin dihilangkan dari medium. Waktu 
inkubasi yang meningkat sampai dengan 6 jam menurunkan aktivitas penghambatan terhadap pelepasan 
histamin, tetapi setelah 6 jam aktivitas penghambatan kembali meningkat. Di samping itu, sel menunjukkan 
kerusakan, perubahan morfologi, penghambatan pertumbuhan sel, dan sel terlepas dari dasar wadah.  
Efek quercetin yang cepat dan reversibel terhadap penghambatan pelepasan histamin nampaknya 
menunjukkan efek pada fase pertama aksi, sedangkan efek pada perubahan morfologi dan kerusakan sel 
berkaitan dengan fase kedua aksi.  
Dengan demikian, quercetin dapat dipandang sebagai senyawa yang beraksi ganda terhadap sel RBL-
2H3.  
Kata kunci : quercetin, histamin, kultur sel RBL-2H3 
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INTRODUCTION 
Flavonoids are benzo--pyrone derivatives with low molecular weight that are found in plants and in 
various food products. The flavonoids display numerous pharmacological activities that affect the immune 
system, platelet aggregation and the relaxation of cardiovascular smooth muscle cells (Formica and Regelson, 
1995). Quercetin is a biflavonoid that inhibits histamine release from basophils and mast cells (Fewtrell and 
Gomperts, 1977). In brain cells from rat, quercetin inhibits protein kinase C (PKC) (Ferriola et al, 1989) and in 
chloroplasts, Ca
2+
-ATPase is inhibited (Shoshan, et al., 1980). Quercetin is also known to be carcinostatic and to 
inhibit cell growth (Middleton, et al., 2000), which makes quercetin interesting as a possible cytotoxic agent in 
addition to the anti-allergic properties of the drug.  
In this study, we used RBL-2H3 cell line (rat basophilic leukemia cells), which have similar properties 
to the mucosal mast cells (Maeyama et al., 1992). The 2H3 cells contain several hundred thousand IgE receptors 
on the membrane surface, and after sensitization with mouse monoclonal IgE, the cells respond to antigen and 
release histamine. Although the mucosal mast cells response to secretagogues and their sensitivity to inhibitors 
are different from those of cutaneous-type mast cells, the mechanism of histamine secretion is supposed to be 
general (Maeyama, et al., 1992). Beside its similarity to mast cells, RBL-2H3 cell is a kind of cancer cell that is 
derived from rat basophil. That makes the cells are also possible to be used to study the cytotoxic effect of a 
compound. 
Mast cell is one of inflammatory cells playing an important role in allergic disease, anaphylaxis and 
inflammation. When activated by antigen-IgE stimulation or other secretagogues, mast cells secrete 
inflammatory mediators, such as histamine, proteases, proteoglycans, cytokines, arachidonic acid and 
chemotactic factors. Histamine is the main preformed mediator released after mast cell activation (Dale and 
Foreman, 1994), formed by decarboxylation of histidine which is catalized by the intracellular enzyme histidine 
decarboxylase, and is stored in granules within the cell (Watanabe, et al., 1991). For exocytosis, activation of 
protein kinase C, PKC, and/or elevation of [Ca
2+
]i is necessary. 
There is a wide phenotypic heterogeneity among mast cells, both in humans and animals. In humans, it 
is complicated to define the different types of mast cells exactly, but there are several types observed. In rats, at 
least two types of mast cells can be distinguished depending on their site of differentiation: connective tissue 
mast cells (CTMC) and mucosal mast cells (MMC). CTMC have predominantly the proteoglycan heparin in 
their granules, can be stained with safranin and contain the neutral protease rat mast cell protease I, RMCP I 
(Foreman, 1994). Mucosal mast cells, MMC, are smaller, have less histamine content, contain chondroitin 
instead of heparin and can not be stained with safranin. MMC contain the neutral protease RMCP II, which is 
similar to the actions of RMCP I (Foreman, 1994). For obscure reasons, polybasic peptides, such as compound 
48/80 and substance P, exclusively release histamine from some types of mast cells, including rat peritoneal 
mast cells (CTMC-like cells), but not 2H3 cells. 
The aim of the present study is to investigate the effects of quercetin on histamine release and 
synthesis, and to study whether the inhibitory effect is reversible or irreversible after various incubation times 
with the drug. Histamine release was assayed using HPLC-fluorometry, and the HDC-activity was examined to 
assay histamine synthesis. The side effects of quercetin, such as the reduction of cell growth, decreased cell 




Chemicals and drugs 
Fetal calf serum (FCS) was purchased from JRH Bioscience (USA). Dinitrophenylated bovine serum 
albumine (DNP-BSA24-BSA, which consists of 24 moles dinitrophenol bound per 1 mol BSA) was given by Dr. 
H. Metzger, NIH (Bethesda, MD, USA), and monoclonal IgE against DNP-BSA24-BSA was purified from the 
supernatant in IgE-producing hybridoma which was obtained in our laboratory. MEM was purchased from 
Gibco BRL (USA). Phorbol myristyl acetate (PMA) was purchased from Sigma (St. Louis, MO, USA). 
Histamine diphosphate, thapsigargin and quercetin dihydrate were obtained from Wako (Osaka, Japan). PIPES 
was purchased from Dojindo Lab (Kumamoto, Japan). Other chemicals were of the highest grade commercially 
available. 
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Methods 
Culture of RBL-2H3 cells and treatment with various agents 
RBL-2H3 cells were maintained in a flask with Eagle’s minimum essential medium (MEM) 
supplemented with 15% fetal calf serum and antibiotics in a humidified atmosphere of 5% CO2 in air according 
to Barsumian et al. (1981). For histamine assay, 2H3 cells were incubated overnight in 24-well culture plates 
(0.2 x 10
6
 cells/well) and sensitized with monoclonal IgE against DNP-BSA (0.5 g/ml).  
 
Assay of histamine release 
Quercetin (working concentration 20 M, unless otherwise stated) was added to specified wells, and 
the cells were pre-incubated for 10 min., 30 min., 2, 4, 6, 12, 24 or 48 hours. The quercetin was prepared as a 
stock solution of 60 mM in DMSO. After incubation, the cells were washed with 0.5 ml PIPES buffer (25 mM 
PIPES, 119 mM NaCl, 5 mM KCl, 5.6 mM glucose, 0.4 mM MgCl2, 1 mM CaCl2, 40 mM NaOH, 0.1 % BSA, 
pH 7.2). The subsequent incubation for 30 minutes was done in PIPES buffer alone or with the following 
challengers: thapsigargin (0.5 M) or DNP-BSA (20 ng/ml). Selected wells also contained quercetin (20 M). 
Thapsigargin and DNP-BSA were prepared as stock solutions in PIPES buffer, 5 M and 200 ng/ml, 
respectively. 
To assay the floating cells, supernatants from cell suspensions that had been incubated for 48 hours 
with quercetin (20 M), were carefully collected and centrifuged at 300 x g for 5 min. The pellet was washed 
and suspended in MEM, and put in a small flask in 37
o
C. The suspension was later transferred to a tube, 
centrifuged at 300 x g for 5 min and re-suspended in PIPES buffer. 200 l each were transferred to Eppendorf 
tubes, which were incubated for 30 min with PIPES buffer containing thapsigargin (0.5 M), DNP-BSA (20 
ng/ml), or PIPES buffer only.  
 
Assay of histamine content 
Histamine released in the supernatants was assayed by HPLC-fluorometry according to Yamatodani, et 
al. (1985). Briefly, one hundred microliters of cell medium from each well and from the 24 tubes with the 
floating cells were centrifuged at 300 x g for 5 min. To 50 l of supernatant, 250 l perchloric acid (3%) and 30 
l KOH/KH2PO4  (2 M and 1 M, respectively) was added.  The mixture was centrifuged at 10 000 x g for 20 
min, and each of the supernatants was directly injected onto a column packed with TSKgel SP-2SW Cation 
Exchanger (Tosoh, Tokyo, Japan). At a flow rate of 0.6 ml/min, histamine was eluted with potassium phosphate 
(0.25 M). The histamine was post-labeled with o-phthalaldehyde in alkaline conditions, and detected 
fluorometrically (F1080 Fluorometer, Hitachi, Tokyo, Japan), using excitation and emission wavelengths of 360 
and 450 nm, respectively.  
To obtain the total content of histamine in the cells, cell suspensions were diluted 5 times and 
sonicated. Fifty microliters of each suspension was then mixed with perchloric acid and KOH/KH2PO4 and 
proceeded with as described above. 
To calculate the percentage of net histamine release, the spontaneous histamine release and percentage 










        (Watanabe et al., 1991). 
net HA release (%) = ch al l enged  HA-rel ease  (p mo les)  -  spontaneous HA-rel ease  (p moles)  x 100 
total HA-release (pmoles)-spontaneous release (pmoles) 
 
 
spontaneous HA release (%) = HA-re lease wi thout drugs (pmoles)     x 100 
total HA-content (pmoles) 
 
uinhibition (%) = HA-release wi thout  drugs (pmoles)  -  HA-re lease wi th drugs   x 100 
HA-release without drugs 
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Extraction of HDC and assay of its activity 
Cells were pre-incubated with quercetin (30 uM) on a 24-well plate at 37
o
C, and then incubated with 
MEM containing, phorbol myristate acetate, (10 nM) for 4 hours.  Then, the media were discarded, and the 
attached cells were suspended in 0.75 ml ice cold HDC buffer (0.1 M potassium phosphate buffer pH 6.8, 0.2 
mM dithiothreitol, 0.01 mM pyridoxal 5’-phosphate, 1 % (w/v) polyethylene glycol (average molecular weight: 
300 g/mole) and 100 g/ml phenyl-methylsulfonyl flouride) and sonicated for 20 sec. The homogenate was 
centrifuged at 10 000 x g for 20 min, and the supernatant was dialyzed three times against 50 volumes of HDC 
buffer. The enzyme was incubated for 2 hours at 37
o
C in 1.0 ml HDC-buffer containing 0.25 mM L-histidine, 
and the reaction was stopped by adding 0.04 ml perchloric acid (6.2 M). It was then added with 20 l PCA 
(60%) and 42l KOH/KH2PO4  (2 M and 1 M, respectively) and centrifuged at 10 000 x g for 20 min, the 
histamine in the supernatant was assayed using HPLC as described above. The protein amount was analized 
using a Bio-Rad protein assay kit. HDC activity is expressed as formation of histamine (pmoles) per min per mg 
protein. 
 
Trypan blue staining 
Cells were incubated at 37
o
C for 12, 24 or 48 hours in 400 l RPMI media (without phenol red), with 
or without quercetin (20 uM). To study the floating cells, media from selected wells were transferred to new 
wells after incubation, and 400 l RPMI media without quercetin was added to the old wells.  Cells were stained 
with 10 l trypan blue (0.4 %), and pictures were taken in an inverse light microscope for observation. Also, 
assay of histamine content of the cells was performed using HPLC as previously described. 
 
RESULT AND  DISCUSION 
 
Effect of quercetin on histamine release 
Quercetin showed inhibitory effect on histamine release induced by DNP-BSA from IgE-sensitized 
2H3 cells in a concentration dependent manner (Fig. 1a). Induction of histamine release by thapsigargin was 
also inhibited by quercetin (Fig. 1a). 
 
Effect of quercetin on HDC-activity 
When the cells were pre-incubated with quercetin, the HDC-activity induced by PMA was inhibited 
(Fig. 1b), indicating that histamine synthesis was inhibited by quercetin. 
Effect of quercetin after various incubation timesIgE-sensitized cells were challenged with DNP-BSA 
and thapsigargin after different incubation times with quercetin, both experiments showing similar results. 
When quercetin was removed by washing before challenging, the property of releasing histamine was recovered 
independently of incubation time (Fig. 2a and b, white bars). If the quercetin was not removed before 
challenging, histamine release was inhibited, but after 6 hours incubation with quercetin the inhibition was 
decreased (Fig. 2a-d). Further incubation gave rise to increased inhibition (Fig. 2a-d).  
 
Recovery of histamine releasing ability 
If quercetin is removed from the cell medium before challenging, the histamine release will no longer 
be inhibited. Fig. 3 shows the time course of histamine release from IgE-sensitized cells challenged with DNP-
BSA or thapsigargin, with or without pre-incubation with quercetin.  
 
Damaged cells and morphological changes 
After 48 hours incubation with several concentrations of quercetin, some of the cells tended to detach 
from the underlying surface with increasing concentration of the drug. Histamine content of the attached and 
detached cells respectively, was assayed and the results was established at Fig. 4. The attached cells were 
stained with trypan blue, and the number of damaged cells increased with higher concentrations of quercetin 
while the total number of cells was decreased. Furthermore, the morphology of the cells changed from the 
characteristic appearance of 2H3 cells to more spherically shaped cells that lacked processes extending from the 
cell body. 
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Fig.1a.Concentration-response curve of quercetin effect on histamine release from RBL-2H3 cells. Histamine 
release was induced by DNP-BSA or thapsigargin. Positive SEM of duplicates of values are shown if 
exceeding 0.01.  
Fig.1b. HDC-activity measured after pre-incubation with vehicle, quercetin, PMA or both PMA and quercetin.  
           Positive SEM of duplicates of values are shown if exceeding 0.01. 
Fig. 2a. Histamine release from IgE-sensitized cells after incubation with quercetin and challenge with        
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Fig. 2c. Histamin release after incubation with quercetin and challene with 
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After incubation with 20 uM quercetin, cells were only slightly affected by the damaging effect, cell 
growth inhibition and the morphologically changing effects of the drug, while the inhibitory effect on histamine 
release was significant. This is the concentration of quercetin used in most experiments in this study. 
It seems that the effects of quercetin on 2H3 cells can be divided into at least two phases; the first 
occurring if the cells were incubated for a shorter time than 6 hours, and the second one was after 6 hours 
incubation or longer. This study can not determine the reasons for the biphasic behavior of quercetin, but the 
different effects are discussed. The points represents inhibition of challenge after removal of quercetin. Positive 




Fig. 2c.Histamin release after incubation with quercetin and challenge wiyh thapsigargin. Positive SEM 
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Inhibition of histamine release and synthesis 
As expected, quercetin inhibited histamine release induced by DNP-BSA in a concentration dependent 
manner, supporting previously published data on the inhibitory effect of quercetin on tyrosine kinases ((Ferriola 
et al, 1989), since the lyn- and syk tyrosine kinases associated with the FcRI most probably are inhibited. 
 The histamine release triggered by thapsigargin was also inhibited (Fig. 1a), which might indicate an 
inhibitory effect of quercetin on Ca
2+
-ATPases in the cell membrane that regulates Ca
2+
-influx, which in this 
case prevents the cell from releasing histamine by preventing sufficient elevation of [Ca
2+
]i. 
Fig. 1b shows that quercetin to some extent inhibits PMA-induced HDC-activity, which most likely 
contributes to the decreased content of the cells. The results also implies that quercetin inhibits PKC since PMA 
is a specific protein kinase activator. However, the inhibition of the HDC activity was not complete, which 
stresses the importance of other sites of inhibition. 
 
Fig.2d. Inhibition of histamine release induced by thapsigargin after various incubation times with quercetin 
 
In conclusion, there are several sites of action for the inhibitory effect of quercetin on histamine 
release and synthesis. The points represents inhibition of challenge after removal of quercetin. Positive SEM of 
duplicates of values are shown if exceeding 0.01. 
 
Dual behavior of quercetin 
Quercetin inhibited histamine release after incubation for 0.5-4 hours (Fig. 2), but notably, if quercetin 
was removed before challenging, the cells recovered their ability to release histamine (Fig. 2a and c). This effect 
was observed after challenge with either DNP-BSA or thapsigargin. Fig. 3 shows that IgE-sensitized cells have 
almost the same responsiveness to DNP-BSA independently of the time course after removal of quercetin 
(recovery time) compared to control. These results suggest that the inhibitory effect on histamine release of 
quercetin could be quickly reversed. The chemical structure of quercetin (Fig. 5) reveals a rather hydrophobic 
compound, which makes it suitable for interactions within the plasma membrane. If a part of the inhibitory 
effect on histamine release is due to interactions of quercetin and enzymes in, or in the proximity of, the plasma 
membrane, this could be one of the explanations why the inhibitory effect is so quickly eliminated by washing. 
However, if a portion of the quercetin is trapped in the cytosol, or more likely in organelles, is not 
known. Probably a small amount of quercetin remains in the cells since it has been reported that the drug has 
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Fig. 3. Histamine release from 2H3 cells after various recovery times, with or without pre-incubation  
                    with quercetin. Positive SEM of duplicates of values are shown if exceeding 0.01. 
 
                         
 Fig. 4. Histamine content of attached and detached cells. Positive SEM of duplicates of values are shown if 
exceeding 0.01. 
 
When the cells were incubated for about 6 hours, the inhibitory effect of quercetin seemed to decrease, 
while it would increased again when was incubated longer (Fig. 2b and d). These data propose that quercetin 
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Cell changes 
After 48 hours incubation, the cells became round, lacked extending processes and the number of 
attached cells drastically decreased when the concentration of quercetin was increased (Fig. 5). Also, the cells 
exhibited a high degree of cell damage with increasing concentration of the drug as visualized by trypan blue 
exclusion. The fraction of detached cells increased while their histamine content was reduced, which partly 
could be explained by the reduction of HDC-activity. However, the results prompted for a phenotypic change of 
the cells, which means that quercetin most likely exerts effects that was not instantly reversible by removing the 
drug from the medium. One of the effects might involve rearrangement of the actin cytoskeleton, which can lead 
to changes in adhesive properties and morphology of the cells. Polymerizing and depolymerizing of actin 
determines the cytoskeleton, and these reactions are, in addition to the motor protein myosin, regulated by 
[Ca
2+
]i and PKC, which in turn are affected by quercetin. Thus both morphological changes and detachment of 





Fig. 5. Chemical structure of quercetin 
 
It has been reported that quercetin induces apoptosis in tumor cells, such as cultured colorectal tumor 
cells (Richter et al., 1999). In the cell lines HeLa and COLO320 DM, the induction of cytoprotective heat shock 
proteins (hsps) is supressed by quercetin, leading to apoptosis (Yoshida, et al., 1990). Since 2H3 cells origin 
form basophilic leukemia cells, the observed cytotoxicity and cell number decrease in this study might be 
influenced by quercetin-dependent supression of hsps leading to apoptosis, along with the growth inhibitory 
effect of the drug. 
In conclusion, it seems like quercetin has many sites of action of inhibiting the histamine release and 
synthesis, the most important being inhibition of tyrosine kinases, PKC, Ca
2+
-ATPases and HDC. These results 
also suggest that quercetin behaves dually, with a first phase of anti-allergic properties and a latter phase 
dominated by growth inhibition and cytotoxicity. The mechanisms of the two phases are most likely different, 
possibly the previous is mainly sited at/within the plasma membrane, and the latter one located in the cytosol, 
organelles or in the nucleus.  
This dual behavior of quercetin needs to be further analyzed, since it represents both anti-allergic and 
cytotoxic effects. 
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